Bivalirudin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Bivalirudin. Educational only — not medical advice.
Labeled uses
Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Source: FDA labeling via NIH DailyMed (set 4119b710…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.